Pharmacoepidemiology in pregnancy

Thérapie
Justine BeneventChristine Damase-Michel

Abstract

Taking a medication is usually a challenge for a pregnant woman as the beneficial drug effect on the mother has to be considered regarding its potential adverse effects, not only for her but also for her unborn child. As medication use is common in pregnant women, by chance or necessity, it gives the opportunity to evaluate the consequences of prenatal drug exposure in real life through pharmacoepidemiological studies. This paper provides an overview of data sources, study designs and data analysis methods that can be used for pregnancy medication safety studies. In the future, the implementation of responsive international networks may be the keystones of drug evaluation in pregnancy.

References

Oct 23, 1982·Lancet·E Robert, P Guibaud
Apr 23, 1999·Lancet·T Walley, A Mantgani
Nov 30, 2000·Lancet·I LacroixJ L Montastruc
Aug 14, 2003·American Journal of Epidemiology·Sonia Hernández-DíazAllen A Mitchell
Sep 24, 2004·Pharmacoepidemiology and Drug Safety·Christine Damase-MichelJ L Montastruc
Oct 12, 2004·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Marco De SantisAlessandro Caruso
Jun 28, 2005·Reproductive Toxicology·Christof SchaeferReinhard Meister
Apr 15, 2009·European Journal of Clinical Pharmacology·I LacroixC Damase-Michel
May 15, 2009·American Journal of Medical Genetics. Part a·Marlene T AnderkaSonja A Rasmussen
Jun 9, 2009·European Journal of Epidemiology·Jonas F LudvigssonAnders Ekbom
Dec 8, 2009·Basic & Clinical Pharmacology & Toxicology·Kari FuruHenrik Toft Sørensen
Jul 21, 2012·European Journal of Clinical Pharmacology·P G J ter HorstB Wilffert
Feb 22, 2013·Current Opinion in Obstetrics & Gynecology·Johanna P de GraafGouke J Bonsel
Oct 30, 2013·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·B MulderE Hak
Mar 26, 2014·Pharmacoepidemiology and Drug Safety·Rachel A CharltonCorinne S de Vries
Apr 5, 2014·Thérapie·Marleen M H J van GelderNel Roeleveld
Apr 5, 2014·Thérapie·Thierry VialNathalie Bernard
Apr 5, 2014·Thérapie·Elisabeth ElefantDelphine Beghin
Apr 5, 2014·Thérapie·Christine Damase-MichelUNKNOWN les partenaires d’EFEMERIS
Mar 3, 2015·Journal de gynécologie, obstétrique et biologie de la reproduction·O ParantB Guyard-Boileau
Apr 16, 2015·International Journal of Epidemiology·Ragnhild Eek BrandlistuenHedvig Nordeng
Jun 3, 2015·Birth Defects Research. Part A, Clinical and Molecular Teratology·Gábor VermesNándor Ács
Jul 15, 2015·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Linda de JongeMarian K Bakker
Dec 23, 2015·American Journal of Public Health·Pamela HerdIrina Merkurieva
Mar 11, 2016·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·François MontastrucAntoine Pariente
Mar 24, 2016·Contraception·Caroline Moreau, Aline Bohet
Mar 29, 2016·Pharmacoepidemiology and Drug Safety·Caroline Hurault-DelarueChristine Damase-Michel
Apr 12, 2016·International Journal of Epidemiology·Per MagnusCamilla Stoltenberg
Apr 16, 2016·Thérapie·Jacques CaronSophie Gautier
Apr 16, 2016·Thérapie·Jean-Luc FaillieAntoine Pariente
Apr 17, 2016·British Journal of Clinical Pharmacology·Anna-Belle BeauChristine Damase-Michel
May 21, 2016·Thérapie·Laurence LagarceUNKNOWN Association française des centres de pharmacovigilance
Jun 25, 2016·Thérapie·Aurélie GuérinHedvig Nordeng
Jun 29, 2016·Bioanalysis·Marie-Claude BattistaChristiane Auray-Blais
Sep 23, 2016·The Journal of Asthma : Official Journal of the Association for the Care of Asthma·Anna-Belle BeauChristine Damase-Michel
Oct 21, 2016·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Lucie Palosse-CantaloubeChristine Damase-Michel
Nov 20, 2016·Thérapie·Mathilde SalguesIsabelle Lacroix

❮ Previous
Next ❯

Citations

Dec 14, 2019·Thérapie·Débora BertrandValérie Gras-Champel
Jan 12, 2020·Thérapie·Isabelle LacroixChristine Damase-Michel

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Expert Opinion on Drug Safety
Justine BeneventChristine Damase-Michel
Pharmacoepidemiology and Drug Safety
Pharmacoepidemiology and Drug Safety
© 2022 Meta ULC. All rights reserved